Ignite Creation Date:
2025-12-24 @ 3:51 PM
Ignite Modification Date:
2026-02-04 @ 8:03 AM
Study NCT ID:
NCT03020992
Status:
COMPLETED
Last Update Posted:
2021-02-09
First Post:
2017-01-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU
Sponsor:
UCB Biopharma SRL
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-21
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-01-23
Completion Date Type:
ACTUAL
First Submit Date:
2017-01-11
First Submit QC Date:
None
Study First Post Date:
2017-01-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-12-02
Results First Submit QC Date:
None
Results First Post Date:
2020-12-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-20
Last Update Post Date:
2021-02-09
Last Update Post Date Type:
ACTUAL